UMCC 2008.62: Prospective Pilot Study Evaluating the Use of Duloxetine for Treatment of Aromatase Inhibitor-associated Musculoskeletal Symptoms in Breast Cancer Patients.
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2013
At a glance
- Drugs Duloxetine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 16 Aug 2012 Planned end date changed from 1 Jun 2015 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 01 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.